Scholar Rock Holding (SRRK) Capital Expenditures (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Capital Expenditures of $68000.0 in Q1 2026, up 112.5% quarter-over-quarter from $32000.0 in Q4 2025, and down 74.91% on a YoY basis from $271000.0 in Q1 2025.

Scholar Rock Holding (SRRK) Capital Expenditures (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Capital Expenditures history runs 10 years deep, the most recent figure standing at $68000.0 for Q1 2026.

  • In Q1 2026, Capital Expenditures fell 74.91% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at $399000.0 (up 12.08% YoY), while the FY2025 annual figure was $602000.0, up 514.29% from the prior year.
  • Capital Expenditures was $68000.0 for Q1 2026 at Scholar Rock Holding, up from $32000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $952000.0 in Q4 2022 to a low of -$808000.0 in Q3 2022.
  • Historically, Capital Expenditures has averaged $126866.7 across 5 years, with a median of $41000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2025: Capital Expenditures tumbled 119.85% in 2022, then jumped 1984.62% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $952000.0 in 2022, then sank by 95.69% to $41000.0 in 2023, then slumped by 46.34% to $22000.0 in 2024, then surged by 45.45% to $32000.0 in 2025, then jumped by 112.5% to $68000.0 in 2026.
  • The last three Capital Expenditures figures came in at $68000.0 (Q1 2026), $32000.0 (Q4 2025), and $84000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 133.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - -63,220.27
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 68,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 68,000.00
Mar 31, 2026 68,000.00
Dec 31, 2025 32,000.00
Dec 31, 2025 32,000.00
Sep 30, 2025 84,000.00
Sep 30, 2025 84,000.00
Jun 30, 2025 215,000.00
Jun 30, 2025 215,000.00
Mar 31, 2025 271,000.00
Mar 31, 2025 271,000.00
Dec 31, 2024 22,000.00
Dec 31, 2024 22,000.00
Sep 30, 2024 31,000.00
Sep 30, 2024 31,000.00
Jun 30, 2024 32,000.00
Jun 30, 2024 32,000.00
Mar 31, 2024 13,000.00
Mar 31, 2024 13,000.00
Jun 30, 2023 41,000.00
Jun 30, 2023 41,000.00